ATE553087T1 - Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel - Google Patents
Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittelInfo
- Publication number
- ATE553087T1 ATE553087T1 AT04771118T AT04771118T ATE553087T1 AT E553087 T1 ATE553087 T1 AT E553087T1 AT 04771118 T AT04771118 T AT 04771118T AT 04771118 T AT04771118 T AT 04771118T AT E553087 T1 ATE553087 T1 AT E553087T1
- Authority
- AT
- Austria
- Prior art keywords
- chronic obstructive
- respiratory disease
- group
- obstructive respiratory
- agent
- Prior art date
Links
- 239000003814 drug Substances 0.000 title abstract 2
- 229940124597 therapeutic agent Drugs 0.000 title abstract 2
- 230000001684 chronic effect Effects 0.000 title 2
- 230000000414 obstructive effect Effects 0.000 title 2
- 208000023504 respiratory system disease Diseases 0.000 title 2
- 239000003795 chemical substances by application Substances 0.000 title 1
- 125000000217 alkyl group Chemical group 0.000 abstract 3
- 125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 3
- 125000002252 acyl group Chemical group 0.000 abstract 2
- 125000003342 alkenyl group Chemical group 0.000 abstract 2
- DXKZKYOSLNTYKH-UHFFFAOYSA-N 7-amino-1h-quinolin-2-one Chemical class C1=CC(=O)NC2=CC(N)=CC=C21 DXKZKYOSLNTYKH-UHFFFAOYSA-N 0.000 abstract 1
- 208000006545 Chronic Obstructive Pulmonary Disease Diseases 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 125000003710 aryl alkyl group Chemical group 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4704—2-Quinolinones, e.g. carbostyril
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2003203699 | 2003-07-30 | ||
| PCT/JP2004/011013 WO2005012251A1 (ja) | 2003-07-30 | 2004-07-27 | 慢性閉塞性肺疾患治療剤及びそれを用いた慢性閉塞性肺疾患の治療方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE553087T1 true ATE553087T1 (de) | 2012-04-15 |
Family
ID=34113624
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04771118T ATE553087T1 (de) | 2003-07-30 | 2004-07-27 | Therapeutisches mittel gegen chronische obstruktive atemwegserkrankung und verfahren zur behandlung von chronisch obstruktiver atemwegserkrankung mit diesem mittel |
Country Status (11)
| Country | Link |
|---|---|
| US (2) | US8980914B2 (de) |
| EP (1) | EP1650191B1 (de) |
| KR (1) | KR101100659B1 (de) |
| CN (1) | CN100422155C (de) |
| AT (1) | ATE553087T1 (de) |
| AU (1) | AU2004261527B2 (de) |
| CA (1) | CA2533919C (de) |
| DK (1) | DK1650191T3 (de) |
| ES (1) | ES2382937T3 (de) |
| TW (1) | TWI344365B (de) |
| WO (1) | WO2005012251A1 (de) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2943725B2 (ja) | 1996-01-17 | 1999-08-30 | 大日本インキ化学工業株式会社 | キノリノン誘導体及びそれを有効成分とする抗アレルギー剤 |
| US6624181B1 (en) * | 1997-02-28 | 2003-09-23 | Altana Pharma Ag | Synergistic combination |
| TW430656B (en) * | 1997-12-03 | 2001-04-21 | Dainippon Ink & Chemicals | Quinolinone derivative, method for preparing the same, and anti-allergic agent |
| KR100908418B1 (ko) * | 2001-06-20 | 2009-07-21 | 액티버스 파마 컴퍼니 리미티드 | 퀴놀리논 유도체 의약 조성물 및 그의 제조 방법 |
-
2004
- 2004-07-27 CA CA2533919A patent/CA2533919C/en not_active Expired - Fee Related
- 2004-07-27 KR KR1020067001758A patent/KR101100659B1/ko not_active Expired - Fee Related
- 2004-07-27 AU AU2004261527A patent/AU2004261527B2/en not_active Ceased
- 2004-07-27 ES ES04771118T patent/ES2382937T3/es not_active Expired - Lifetime
- 2004-07-27 AT AT04771118T patent/ATE553087T1/de active
- 2004-07-27 EP EP04771118A patent/EP1650191B1/de not_active Expired - Lifetime
- 2004-07-27 TW TW093122392A patent/TWI344365B/zh not_active IP Right Cessation
- 2004-07-27 US US10/565,828 patent/US8980914B2/en not_active Expired - Lifetime
- 2004-07-27 CN CNB2004800217130A patent/CN100422155C/zh not_active Expired - Fee Related
- 2004-07-27 DK DK04771118.9T patent/DK1650191T3/da active
- 2004-07-27 WO PCT/JP2004/011013 patent/WO2005012251A1/ja not_active Ceased
-
2015
- 2015-02-16 US US14/623,146 patent/US20150157621A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| EP1650191A1 (de) | 2006-04-26 |
| EP1650191B1 (de) | 2012-04-11 |
| CA2533919A1 (en) | 2005-02-10 |
| WO2005012251A1 (ja) | 2005-02-10 |
| US20060235045A1 (en) | 2006-10-19 |
| KR20060041286A (ko) | 2006-05-11 |
| DK1650191T3 (da) | 2012-05-07 |
| TWI344365B (en) | 2011-07-01 |
| AU2004261527B2 (en) | 2010-09-23 |
| EP1650191A4 (de) | 2008-08-20 |
| KR101100659B1 (ko) | 2012-01-03 |
| CA2533919C (en) | 2010-10-12 |
| AU2004261527A1 (en) | 2005-02-10 |
| CN100422155C (zh) | 2008-10-01 |
| CN1829693A (zh) | 2006-09-06 |
| US20150157621A1 (en) | 2015-06-11 |
| US8980914B2 (en) | 2015-03-17 |
| TW200509927A (en) | 2005-03-16 |
| ES2382937T3 (es) | 2012-06-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20060971L (no) | Pyridazinderivater og deres anvendelse som terapeutiske midler | |
| ATE375341T1 (de) | Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen | |
| DE60128258D1 (de) | Indanylderivate zur Behandlung von Atemwegserkrankungen | |
| HRP20090281T1 (hr) | 1,2,3,4-tetrasubstituirani indol za liječenje respiratornih bolesti | |
| WO2005056524A3 (en) | Therapeutic agents useful for treating pain | |
| PA8575401A1 (es) | Derivados de heteroarilamida benzocondensada de tienopiridinas utiles como agentes terapeuticos, composiciones farmaceuticas que incluyen a los mismos y metrodos para su uso | |
| DE69521424D1 (de) | Benzofuran derivate und ihre verwendung als inhibitoren der knochenresorption | |
| NO20051209L (no) | Pyrazolderivater, medisinske sammensetninger inneholdende slike, medisinsk anvendelse derav samt intermediater for samme | |
| NO20062691L (no) | Azabicykliske heterocykler som cannabinoide reseptormodulatorer | |
| DE602004029580D1 (de) | Substituierte indolderivate für eine pharmazeutische zusammensetzung zur behandlung von atemwegserkrankungen | |
| CY1111951T1 (el) | Φαινυλο-καρβοξαμιδικες ενωσεις χρησιμες για την αντιμετωπιση πονου | |
| UA85708C2 (ru) | Лекарственные комбинации, содержащие бензоксазины, для лечения заболеваний дыхательных путей | |
| BR0210122A (pt) | Composto ou um sal farmaceuticamente aceitável do mesmo, método para o tratamento ou prevenção de uma doença, uso do composto ou de seu sal, e, método para preparar o mesmo | |
| DE602005007339D1 (de) | Nebivolol und dessen pharmazeutisch unbedenkliche salze, herstellungsverfahren und pharmazeutische zusammensetzungen von nebivolol | |
| DE60318839D1 (de) | 2,6-chinolinyl- und 2,6-naphthylderivate und deren verwendungen zur behandlung von vla-4 bezogenen krankheiten | |
| BR0316723A (pt) | Derivados de anilinopirazol úteis para o tratamento de diabetes | |
| DE69834500D1 (de) | Xanthinderivative zur behandlung von hirnischämie | |
| NO20065060L (no) | Farmasoytiske kombinasjoner inneholdende benzoksazin for behandling av respiratoriske forstyrrelser | |
| DE602004002394D1 (de) | (3-ä3-'(2,4-BIS-TRIFLUORMETHYL-BENZYL)-(5-ETHYL-PYRIMIDIN-2-YL)-AMINOÜ-PROPOXYü-PHENYL)-ESSIGSÄURE UND VERWANDTE VERBINDUNGEN ALS MODULATOREN VON PPARS UND VERFAHREN ZUR BEHANDLUNG VON STOFFWECHSELSTÖRUNGEN | |
| DE60035429D1 (de) | Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen | |
| EP1637517A4 (de) | 2-aminobicyclo¬3.1.0|hexan-2,6-dicarbonsäureesterderivat | |
| ATE157871T1 (de) | Arzneimittel zur therapeutischen und prophylaktischen behandlung von krankheiten, die durch hyperplasie der glatten muskelzellen bedingt sind | |
| NO20052699L (no) | 4(fenylpiperazinyl-metyl)benzamid-derivater og deres anvendelse ved behandling av smerte og gastrointestinale lidelser. | |
| EA200701181A1 (ru) | Лекарственные средства, предназначенные для лечения или предупреждения фиброзных заболеваний | |
| KR950032171A (ko) | 옥소피리디닐퀴녹살린 유도체 |